Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
European Journal of Pharmacology|February 15, 2011
Desirable properties of β3-adrenoceptor agonists: implications for the selection of drug development candidatesMartin C Michel, Hana Cernecka, Peter Ochodnicky
Pharmacology & Therapeutics|April 23, 2011
β-adrenoceptor agonist effects in experimental models of bladder dysfunctionMartin C Michel, Peter Ochodnicky, Yukio Homma, et al.
Nature Reviews. Urology|October 10, 2012
Neurotrophins as regulators of urinary bladder functionPeter Ochodnicky, Célia D Cruz, Naoki Yoshimura, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|June 13, 2012
Specificity evaluation of antibodies against human β3-adrenoceptorsHana Cernecka, Peter Ochodnicky, Wouter H Lamers, et al.
European Journal of Pharmacology|August 18, 2009
Rapid large artery remodeling following the administration and withdrawal of calcium channel blockers in spontaneously hypertensive ratsVaclav Vaja, Peter Ochodnicky, Peter Krenek, et al.
Journal of Cardiovascular Pharmacology|June 24, 2006
Microalbuminuria and endothelial dysfunction: emerging targets for primary prevention of end-organ damagePeter Ochodnicky, Robert H Henning, Richard P E van Dokkum, et al.
Journal of Receptor and Signal Transduction Research|August 19, 2017
High glucose induces HGF-independent activation of Met receptor in human renal tubular epitheliumLucia Mesarosova, Peter Ochodnicky, Jaklien C Leemans, et al.
American Journal of Physiology. Renal Physiology|February 26, 2016
Renal endothelial function is associated with the anti-proteinuric effect of ACE inhibition in 5/6 nephrectomized ratsSimone Vettoretti, Peter Vavrinec, Peter Ochodnicky, et al.
Journal of Cellular and Molecular Medicine|March 14, 2015
Perinatally administered losartan augments renal ACE2 expression but not cardiac or renal Mas receptor in spontaneously hypertensive ratsJan Klimas, Michael Olvedy, Katarina Ochodnicka-Mackovicova, et al.
Journal of Nephrology|July 29, 2006
Endothelial dysfunction in chronic kidney disease: determinant of susceptibility to end-organ damage and therapeutic responsePeter Ochodnicky, Simone Vettoretti, Robert H Henning, et al.
Pageof 3